EP1506314A4 - Complement mediated assays for in vivo and in vitro methods - Google Patents

Complement mediated assays for in vivo and in vitro methods

Info

Publication number
EP1506314A4
EP1506314A4 EP02806678A EP02806678A EP1506314A4 EP 1506314 A4 EP1506314 A4 EP 1506314A4 EP 02806678 A EP02806678 A EP 02806678A EP 02806678 A EP02806678 A EP 02806678A EP 1506314 A4 EP1506314 A4 EP 1506314A4
Authority
EP
European Patent Office
Prior art keywords
vivo
vitro methods
complement mediated
mediated assays
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02806678A
Other languages
German (de)
French (fr)
Other versions
EP1506314A2 (en
Inventor
Elliot R Ramberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cygene Inc
Original Assignee
Cygene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygene Inc filed Critical Cygene Inc
Priority to EP08003771A priority Critical patent/EP1921451A3/en
Publication of EP1506314A2 publication Critical patent/EP1506314A2/en
Publication of EP1506314A4 publication Critical patent/EP1506314A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP02806678A 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods Withdrawn EP1506314A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08003771A EP1921451A3 (en) 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29261601P 2001-05-22 2001-05-22
US292616P 2001-05-22
US29732101P 2001-06-11 2001-06-11
US297321P 2001-06-11
US32402901P 2001-09-21 2001-09-21
US324029P 2001-09-21
PCT/US2002/016302 WO2003063763A2 (en) 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP08003771A Division EP1921451A3 (en) 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods

Publications (2)

Publication Number Publication Date
EP1506314A2 EP1506314A2 (en) 2005-02-16
EP1506314A4 true EP1506314A4 (en) 2005-08-24

Family

ID=27670579

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02806678A Withdrawn EP1506314A4 (en) 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods

Country Status (5)

Country Link
EP (1) EP1506314A4 (en)
JP (1) JP2005516198A (en)
AU (1) AU2002365902A1 (en)
CA (1) CA2447892A1 (en)
WO (1) WO2003063763A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056456A2 (en) * 2000-02-02 2001-08-09 Cygene, Inc. Methods and compositions for detection of disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056456A2 (en) * 2000-02-02 2001-08-09 Cygene, Inc. Methods and compositions for detection of disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARDONE F ET AL: "A role for complement in transmissible spongiform encephalopathies.", NATURE MEDICINE. APR 2001, vol. 7, no. 4, April 2001 (2001-04-01), pages 410 - 411, XP002314397, ISSN: 1078-8956 *

Also Published As

Publication number Publication date
WO2003063763A3 (en) 2004-12-09
WO2003063763A2 (en) 2003-08-07
JP2005516198A (en) 2005-06-02
AU2002365902A1 (en) 2003-09-02
EP1506314A2 (en) 2005-02-16
CA2447892A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
GB0221053D0 (en) Single-molecule in vitro evolution
IL165804A0 (en) In vitro fertilisation
AU2002360670A8 (en) Method and related composition employing nanostructures
AU2002322211A1 (en) Methods and compisitions for activation human t cells in vitro
GB0110544D0 (en) Improvements in substrates
GB0321692D0 (en) Articles having raised features and methods for making the same
AU4215901A (en) Methods and compositions for immunoregulation
IL161472A0 (en) In vitro micro-organs, and uses related thereto
AU2002318482A1 (en) Quantitative in vitro bone induction assay
GB0111218D0 (en) Assays methods and means
AU2001271483A1 (en) Method for imaging inclusions and/or alpha case in articles
AU2002346446A1 (en) Methods and compositions in checkpoint signaling
AU2002306461A1 (en) In vivo delivery methods and compositions
AU2001253812A1 (en) In vivo loading of mhc
EP1506314A4 (en) Complement mediated assays for in vivo and in vitro methods
AU2003282241A8 (en) Antibodies for in vitro use
GB9917564D0 (en) Improvements in refining
GB0202311D0 (en) Refractory articles and methods for producing refractory articles
AU2002219190A1 (en) Method for determining skin ageing in vitro
GB0228603D0 (en) Ceramic articles and their manufacture
AU2002364783A8 (en) Purified polypeptides involved in general metabolism
AU2002238794A1 (en) Methods and compositions involved in groucho-mediated differentiation
GB2370038B (en) A method for in vitro molecular evolution of protein function
AU2002237928A1 (en) Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo
GB0100732D0 (en) In vitro test media

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031202

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 35/18 B

Ipc: 7G 01N 33/564 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050711

17Q First examination report despatched

Effective date: 20060526

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071228